Hi all, a pioneering new chondrosarcoma research project funded by BCRT has been announced today. Full details and link below We’re delighted to announce we have awarded Dr William Cross, from UCL Cancer Institute, £70,000 to focus on…

In 9 days check out the webinar on Progress in Chondrosarcoma Research. Meet Adrienne Flanagan, Professor of Musculo- Skeletal Pathology at University College London’s Cancer Institute. As a highly accomplished medical researcher, Dr. Flanagan…

No Treatment Options Left: Fighting and Surviving Inoperable Cancer by Mike Snyder After facing the pain and turmoil of losing his left leg to a rare bone cancer called chondrosarcoma, Mike Snyder and his family thought their cancer battle was…

Meet Adrienne Flanagan, Professor of Musculo- Skeletal Pathology at University College London’s Cancer Institute. As a highly accomplished medical researcher, Dr. Flanagan works closely with patient groups and focuses on identifying the genetic…

Interesting article suggesting bone (and other) cancers contain a microenvironment conducive to distinctive bacterial populations https://medicalxpress.com/…/2020-05-cells-bacteria-cancer.h… Cancer cells are comfy havens for bacteria. That…

Mike Snyder, a CS Warrior from Albuquerque, New Mexico and author of his book entitled: No Treatment Options Left: Fighting and Surviving Inoperable Cancer, contributed the first of many commentaries to provide straightforward information to CS…

Please click the link below and register for the webinar on Progress on Research in Chondrosarcoma with Professor Adrienne Flanagan on June 26

 Did You Know? Chondrosarcoma is an extremely rare form of cancer that accounts for only about 20% of malignant bone tumors and is diagnosed in approximately 600 patients each year in the United States. Not only is Chondrosarcoma difficult to…